Pre-clinical studies demonstrated that osteoclasts modulation by DMF plays a key role in rheumatoid arthritis (RA): particularly, DMF leads to a decrease in receptor activator of nuclear factor kappa-B ligand (RANKL) levels after ROS generation through Nrf2 activation. The gene discussed is NFE2L2; the disease is rheumatoid arthritis.